Click to Enlarge
Facebook
Twitter
The Financial Times’ main story focuses on a battle over the future of UK drug manufacturing giant GSK. US hedge fund Elliott Management, known for using its shareholdings to put pressure on companies’ management teams, has bought a multi-billion pound stake in GSK amid concerns by shareholders over the firm’s pipeline of future drugs and its R&D spending.

Financial Times Front Page 23rd of December 2024

Nick Candy has pledged to help Reform UK disrupt the political landscape by supporting policies aimed at reducing the influence of established parties, with plans to introduce a law on fair donations and the backing of affluent supporters, positioning the party as a formidable force in upcoming elections.

Read More »